Bone Health Drugs Linked to 24% Lower Dementia Risk

A medication millions take for bone health might also protect their brains from Alzheimer's disease.

Researchers studying 121,492 adults over age 60 in Hong Kong found that people taking nitrogen-containing bisphosphonates (NBPs) had a 24% lower risk of developing dementia compared to those taking other osteoporosis drugs. Compared to people taking no bone medication at all, the risk dropped by 16%.

NBPs include common medications like alendronate and risedronate that doctors prescribe to slow bone loss and prevent fractures. All participants in the study had recently been diagnosed with osteoporosis or suffered serious fractures but had never taken bone medication before.

The discovery builds on growing evidence of what scientists call the "bone-brain axis." Dr. Ching-Lung Cheung from the University of Hong Kong explained that previous studies already showed people with low bone mass face higher dementia risks later in life.

"This highlights the importance of maintaining good bone health, which may also help reduce the risk of dementia," Cheung told reporters.

The research, published in Alzheimer's & Dementia, tracked only Chinese participants, so scientists need to confirm whether the same benefits apply to other populations. The team also lacked information about factors like education level, social connection, and how severe participants' osteoporosis was.

Why This Inspires

This study represents hope on two fronts. For the estimated 54 million Americans living with low bone density, their prescribed medication might be doing double duty protecting their futures. And for the millions more worried about cognitive decline, it suggests maintaining bone health through treatment could be one more tool in the prevention toolkit.

The researchers aren't recommending doctors prescribe bisphosphonates specifically for dementia prevention yet. Clinical trials need to confirm the connection first. But the findings offer encouraging evidence that caring for one part of our health can create unexpected benefits elsewhere.

Cheung and his team hope their work inspires patients and doctors to consider the full range of benefits when treating osteoporosis. The next step is confirming these results through controlled trials that could reshape how we approach brain health in older adults.

The message is clear: taking care of our bones today might help us remember tomorrow.